US Distribution Update

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

24 February 2021

Zoetic International plc

('Zoetic' or the 'Group')

Update on the rollout of the original US Distribution Agreement

Zoetic (LSE: ZOE), the international CBD group, is pleased to provide the following update on its operations.

Further to the rollout of the new distribution agreement (the 'Agreement'), announced on 19 November 2020, Zoetic's Chill brand of tobacco alternative CBD products is now set to be stocked by one of the largest tobacco-focused retail chains in the US (the 'Retail Chain'), which previously oversaw the growth of one of America's highest-selling tobacco-free nicotine pouch brands. The Group expects to grow market share due to the Retail Chain's significant number of high footfall stores that will sell Chill products from high-visibility point of sale display stands.

The Group will provide further updates in due course as the rollout continues.

Antonio Russo, Co-CEO of Zoetic, commented: "This Agreement marks a pivotal moment in the progress of our US rollout and demonstrates the high calibre of retail placements that our distribution partners continue to make. Our Chill products will now benefit from the established reputation of one of the largest tobacco-focused retail chains in the US. This chain was instrumental in the success of other tobacco alternative products in stores and we are hopeful that we will receive similarly positive results, establishing Chill as one of America's favourite CBD brands."

- Ends -

Media enquiries: